Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Universities, institutes and hospitals at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

85 universities, institutes and hospitals are at Discovery on Target 2026 — 96 presentations on the program. Most represented: University of California, San Francisco (6 on the program), Broad Institute (4 on the program), Massachusetts Institute of Technology (4 on the program). 26 of them have their own page in this guide. As of Oct 8, 2026.

All 510 organizations at Discovery on Target 2026 →

Showing 1–10 of 85 organizations

Organization	Discovery on Target 2026 Attendance
University of California, San Francisco San Francisco, CA
	Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Eli Lilly +3 more Talk Tue Sep 29 10:35am–11:35am Ninhydrin as a Covalent Warhead-Targeting Arginine Lead Generation Strategies Talk Tue Sep 29 11:35am–12:05pm Snapshots of the Cell Surface: Mapping Protein Neighborhoods Using Contact-dependent Antibody Mapping (contactMAP) Antibodies Against Challenging Targets Talk Wed Sep 30 11:50am–12:20pm Targeted Degradation of Extracellular Proteins via Induced Shedding Novel Drug Modalities Talk Wed Sep 30 12:20pm–12:50pm Making "n=1" Therapies Accessible for All with Computational Target Prediction Innovative Discovery Technologies Talk Thu Oct 1 10:05am–10:35am Structure-Guided Engineering of a Conformation-Specific Antibody–Drug Conjugate for AML Antibodies Against Challenging Targets Talk Thu Oct 1 10:35am–11:05am Chemical Strategies to Expand the Therapeutic Window for Targeted Radiotherapy Radioligand Therapies
Broad Institute Cambridge, MA
broadinstitute.org Academic & healthcare Biomedical and genomic research institute in Cambridge, Massachusetts, founded by MIT and Harvard.	Talk Tue Sep 29 9:35am–10:05am From Genetic Validation to Lead Generation: Targeting the CARD9 Signalosome Emerging Drug Targets Talk Tue Sep 29 10:35am–11:05am Diverse Mechanisms of Small Molecule-Induced Protein Degradation Novel Drug Modalities Talk Wed Sep 30 3:05pm–3:35pm Protein Editing Using Proximity-inducing Molecules Novel Drug Modalities Talk Thu Oct 1 3:35pm–3:50pm Novel FGFR2 Biparatopic Antibodies for the Treatment of Cholangiocarcinoma Novel Drug Modalities
Massachusetts Institute of Technology Cambridge, Massachusetts
	Talk Wed Sep 30 9:35am–10:05am Antibody Discovery against Intrinsically Disordered Proteins Antibodies Against Challenging Targets Talk Wed Sep 30 11:50am–12:20pm Peptide–Small Molecule Conjugate Libraries for Hit Discovery and Catalyst Development Next-Generation Conjugates Panel Thu Oct 1 2:25pm–3:20pm Starting Up: Translating Lab Ideas into Commercial Impact Plenary · with Portal Biotechnologies, Kiral Medicines, AIRNA +3 more Talk Thu Oct 1 4:05pm–4:35pm Label-Free Single-Cell Buoyant Mass Profiling Uncovers Hidden T-Cell Heterogeneity and Predicts Immunotherapy Response Innovative Discovery Technologies
University of Michigan Ann Arbor, MI
	Talk Tue Sep 29 9:05am–9:35am Leveraging Structural Ensembles to Modulate the Function of RNAs in Cells Innovative Discovery Technologies Talk Tue Sep 29 10:35am–11:05am Development of Exceptionally Potent, Selective and Orally Active STAT6 Degraders Emerging Drug Targets Talk Wed Sep 30 2:05pm–2:35pm Targeting Gene Transcriptional Complexes by Domain Alteration Chimeras (DALTACs) Novel Drug Modalities Panel Thu Oct 1 7:30am–8:15am Scientific Work in the Age of AI Agents Innovative Discovery Technologies · with Montai Therapeutics, bPrescient
Dana-Farber Cancer Institute Boston, MA
dana-farber.org Academic & healthcare Harvard-affiliated cancer treatment and research center in Boston.	Talk Mon Sep 28 1:35pm–2:05pm Targeting p53 Protein Abundance across TP53 Mutant Cancers with Proximity-Inducing Small Molecules Symposium: Induced Proximity-Based Drug Discovery Talk Mon Sep 28 4:00pm–4:30pm Selectively Targeting Cancer Dependency for Novel Therapy Development Symposium: Induced Proximity-Based Drug Discovery Talk Thu Oct 1 4:35pm–5:05pm Proteolysis Activity Mapping and Substrate Discovery Platform for Identifying Tumor-Activated Biosensors Innovative Discovery Technologies
Yale University New Haven, CT
	Talk Mon Sep 28 9:15am–9:45am Enhancing Inhibition via Chemically Induced Proximity: A RIPTAC Targeting BCL6 and BET Proteins Symposium: Induced Proximity-Based Drug Discovery Talk Tue Sep 29 1:50pm–2:20pm Using DNA-Encoded Libraries to Discover Molecular Glues that bind FKBP12 and Structurally Distinct Targets Lead Generation Strategies Talk Wed Sep 30 3:35pm–4:05pm POSTER SPOTLIGHT: Development of CORTACs as a Small Molecule Strategy to Enhance Degrader Specificity Emerging Drug Targets
Baylor College of Medicine Houston, TX
bcm.edu Academic & healthcare Medical school and biomedical research institution in Houston.	Chair Tue Sep 29 8:30am–8:35am Chairperson's Remarks Novel Drug Modalities Talk Tue Sep 29 11:35am–12:05pm Application of AI and High-Throughput Proteomics for Molecular Glue Discovery Novel Drug Modalities Panel Wed Sep 30 7:30am–8:15am New Screening Tools for Design & Optimization of Molecular Glues Novel Drug Modalities · with SyntheX, Herbert Wertheim UF Scripps Institute Talk Thu Oct 1 10:05am–10:35am Advancing Lead Generation: Overcoming Selectivity Challenges with DNA-Encoded Libraries Lead Generation Strategies
University of Wisconsin–Madison Madison, WI
	Talk Wed Sep 30 12:20pm–12:50pm Investigation of Lysosome-Targeting Receptors for the Selective Degradation of Extracellular and Membrane Proteins Novel Drug Modalities Chair Thu Oct 1 9:00am–9:05am Chairperson's Remarks Radioligand Therapies Talk Thu Oct 1 9:05am–9:35am Opportunities for Integrating Radioligand Therapy in Combined Modality Treatment of Patients with Cancer Radioligand Therapies Chair Thu Oct 1 3:30pm–3:35pm Chairperson's Remarks Radioligand Therapies
Harvard Medical School Boston, MA
	Talk Tue Sep 29 2:20pm–2:50pm An Orthogonal 2D Pooling Strategy for Cysteine-Profiling of Electrophilic Libraries Innovative Discovery Technologies Panel Wed Sep 30 7:30am–8:15am Surge in Proteomics & D2B Screening Methodologies Innovative Discovery Technologies · with Fox Chase Cancer Center, Birdwood Therapeutics Panel Thu Oct 1 7:30am–8:15am Emergence of New Modalities & Their Likelihood of Clinical Success Novel Drug Modalities · with Dewpoint Therapeutics, Tahoe Therapeutics
Brigham and Women's Hospital Boston, MA
brighamandwomens.org Academic & healthcare Harvard Medical School teaching hospital in Boston and a founding member of the Mass General Brigham health system.	Panel Thu Oct 1 7:30am–8:15am Drug Discovery for Healthy Aging Plenary · with Wyss Institute, Rising Tide Strategies Emerging drug targets Talk Thu Oct 1 9:05am–9:35am Nanodisc-Based Platform for HLA Antibody Identification Antibodies Against Challenging Targets